Form 4 Tracker
John R Stuelpnagel

Director · 2 filings · Latest: Aug 11, 2026

10x Genomics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TXG
John R StuelpnagelDirectorAug 11, 2026
Sale
$57.7520,000$1.2M348,436
TXG
STUELPNAGEL JOHN RAug 11, 2026
Proposed Sale
$57.7520,000$1.2M
STUELPNAGEL JOHN RAug 11, 2026
Proposed Sale
$57.7520,000$1.2M